Stocks · Health care · Pharmaceutical Preparations

Opus Genetics, Inc.

IRD Clue Score33
United States Fiscal year ends December CIK 0001228627 Results filed 6 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
George Magrath
3 Nov 2026
Chief Executive Officer
Sell
28,258
$3.90
$110.18K
George Magrath
23 Oct 2026
Chief Executive Officer
Sell
9,591
$3.59
$34.38K
Robert E. Gagnon
23 Oct 2026
Chief Financial Officer
Sold on a plan
14,000
$3.55
$49.65K
Benjamin R Yerxa
23 Oct 2026
President
Sell
25,520
$3.53
$90.13K
Benjamin R Yerxa
23 Oct 2026
President
Sell
7,669
$3.55
$27.24K
Joseph K Schachle
23 Oct 2026
Chief Operating Officer
Sell
4,767
$3.57
$16.99K
Foundation Fighting Blindness Retinal Degeneration Fund
30 Sep 2026
Director
Sell
556,000
$4.96
$2.76M
George Magrath
9 Sep 2026
Chief Executive Officer
Exercised, kept
392,157
$1.15
$450.98K
Cam Gallagher
8 Sep 2026
Director
Exercised, kept
784,314
$1.15
$901.96K
Robert E. Gagnon
3 Sep 2026
Chief Financial Officer
Sell
28,000
$4.54
$127.21K
Robert E. Gagnon
23 Jul 2026
Chief Financial Officer
Sell
7,783
$2.95
$22.94K
George Magrath
23 Jul 2026
Chief Executive Officer
Sell
9,475
$2.95
$27.93K
Joseph K Schachle
23 Jul 2026
Chief Operating Officer
Sell
4,644
$2.94
$13.65K
Benjamin R Yerxa
23 Jul 2026
President
Sell
7,429
$2.97
$22.06K
Foundation Fighting Blindness Retinal Degeneration Fund
18 May 2026
Director
Sell
1,700,000
$4.35
$7.40M
Robert E. Gagnon
23 Apr 2026
Chief Financial Officer
Sell
7,842
$5.18
$40.66K
Ashwath Jayagopal
23 Apr 2026
Chief Scientific & Dev. Ofc.
Sell
7,542
$5.19
$39.16K
George Magrath
23 Apr 2026
Chief Executive Officer
Sell
9,511
$5.22
$49.65K
Rabourn Amy Zaremba
23 Apr 2026
Head of Fin. Quality Assurance
Sell
1,641
$5.20
$8.54K
Joseph K Schachle
23 Apr 2026
Chief Operating Officer
Sell
4,697
$5.22
$24.52K
Benjamin R Yerxa
23 Apr 2026
President
Sell
7,470
$5.24
$39.12K
Ashwath Jayagopal
16 Mar 2026
Chief Scientific & Dev. Ofc.
Sell
3,719
$5.12
$19.05K
George Magrath
16 Mar 2026
Chief Executive Officer
Sell
24,438
$5.21
$127.33K
Rabourn Amy Zaremba
16 Mar 2026
Head of Fin. Quality Assurance
Sell
2,816
$5.25
$14.77K
Joseph K Schachle
16 Mar 2026
Chief Operating Officer
Sell
3,719
$5.25
$19.53K
Cam Gallagher
29 Dec 2025
Director
Buy indirect
83,000
$1.97
$163.42K
Cam Gallagher
29 Dec 2025
Director
Buy
81,000
$1.98
$160.27K
Foundation Fighting Blindness Retinal Degeneration Fund
9 Dec 2025
Director
Sell
4,000,000
$2.15
$8.60M

What was left out

Form 4 filings counted 47
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 0
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 3,673,838
History held since 8 Jan 2007